Graffiti depicts a person wearing personal protective equipment and holding a syringe in their gloved hand against the wall, with a person walking in front of it.

Covid-19 News: NHS drafts plan to vaccinate adults in England by April

By Michael le page
, Clare Wilson
, Jessica Hamzelou
, Sam Wong
, Adam Vaughan
, Conrad Quilty-Harper
and Layal Liverpool

Hope for a future coronavirus vaccine in Paris, France


Latest coronavirus news from 8pm on November 20th

The draft plan from NHS England provides for comprehensive vaccination of adults by early April

A draft of NHS England’s plan for the introduction of a coronavirus vaccine calls for all willing adults in England to be fully vaccinated by early April, provided that adequate doses and other vital supplies are available. Under the NHS England’s draft Covid-19 Vaccine Deployment Program featured in a leaked document dated Nov. 13 by HSJMost doses of the potential vaccine would be given between early January and mid-March at a rate between 4 and 5 million per week. Vaccinations would take place at thousands of “local mass vaccination centers” set up by local general practitioners, plus additional “large mass vaccination centers” in stadiums and conference centers. Priority will be given to healthcare workers and nursing home residents who will start vaccinating in early December, followed by those aged 80 and over, those in their seventies, and those in their late sixties. Adults under 50 could start vaccinations in late January, with the majority being vaccinated in March. The draft plan calls for more than 7 million doses of a vaccine to be available by December. The document makes no mention of which vaccine is used, and it is not known how many doses of the Pfizer and Moderna vaccines will be available by then. The document also gives very few details on how the NHS will overcome the significant logistical problems in the supply of vaccines that require tightly temperature-controlled supply chains.

The US pharmaceutical company Pfizer and the German company BioNTech have applied to the US Food and Drug Administration (FDA) today Emergency approval for their coronavirus vaccine candidate in the United States. This week, the Pfizer BioNTech vaccine was found to be 95 percent effective in Phase III clinical trials. The UK government did 40 million cans pre-ordered of Pfizer vaccines and recently signed an initial agreement with US pharmaceutical company Moderna for 5 million cans preliminary results show the vaccine candidate is nearly 95 percent effective.


Other coronavirus news

Coronavirus infections in England can flatten outAccording to the latest results of a random swab test survey by the National Statistics Office. The estimated daily new infections in England fell slightly in the week ended November 14, to 38,900 new cases per day, compared to 47,700 the previous week. “Those numbers would be the first where we could hope the national lockdown is starting to take effect,” said James Naismith of the University of Oxford in one Explanation. “We know that social restrictions are the most effective way to reduce the number of new infections.”

The World Health Organization has recommended this Ebola treatment Remdesivir should not be used in people hospitalized with covid-19. The FDA approved remdesivir for use in people over 12 years of age who were hospitalized with covid-19 in the last month. “The studies reported so far have shown no effects of remdesivir on survival,” said Martin Landray of the University of Oxford in a Explanation. “This is a drug that has to be given intravenously for 5 to 10 days and costs around £ 2000 per class. So remdesivir isn’t cheap, isn’t convenient, and doesn’t affect the mortality rate of the people at highest risk. “

Personal protective equipment ordered by the UK government may have come from factories that do North Korean slave labor Guardian reported.

The United States Centers for Disease Control and Prevention advised people in the US not to travel for the upcoming Thanksgiving Day.

Coronavirus deaths

Standard image of the new scientist

The global Covid-19 death toll has exceeded 1.36 million. The number of confirmed cases is loud. More than 57.1 million Johns Hopkins Universityalthough the true number of cases will be much higher.

Important information about the coronavirus

Everything you need to know about the pandemic

Where did the coronavirus come from? And other Covid-19 questions were answered

What is covid-19?

You could be spreading the coronavirus without realizing you have it

Which Covid-19 treatments work and how close are we to achieving more?

How does Pfizer’s coronavirus vaccine work?

What to read, see and hear about coronavirus

Race against the virus: chasing a vaccine is a Channel 4 documentary that tells the story of the coronavirus pandemic through the eyes of frontline scientists.

The New York Times evaluates the progress of various vaccine candidates and potential drug treatments for Covid-19 and rates them for effectiveness and safety.

People from COVID-19 is a project shedding light on the experiences of key frontline workers in the UK’s fight against coronavirus through social media.

Belly Mujinga: In Search of Truth is a BBC Panoramic investigation into the death of covid-19 transport worker Belly Mujinga after being reported coughed and spat on by a customer at Victoria Station, London.

Coronavirus, explained on Netflix is ​​a short documentary series that explores the ongoing coronavirus pandemic, efforts to fight it, and ways to manage mental health.

New Scientist Weekly provides updates and analysis on the latest developments in the Covid-19 pandemic. Every week on our podcast, journalists from the magazine discuss the biggest scientific stories that hit the headlines – from technology and space to health and the environment.

COVID-19: The Pandemic That Should Never Have Happened And How To Stop The Next One by Debora Mackenzie is about how the pandemic happened and why it will happen again if we don’t do things differently in the future.

The rules of contagion is about the new science of contagion and the surprising ways in which it shapes our lives and behavior. The author Adam Kucharski is an epidemiologist at the London School of Hygiene and Tropical Medicine in the UK. In his book, he examines how diseases spread and why they stop.

Previous updates

Pedestrians pass festive lights on Oxford Street in London, UKPedestrians pass festive lights on Oxford Street in London, UK

Simon Dawson / Bloomberg via Getty Images

November 19th

The British science advisor warns of “considerable risks” if he makes contacts over Christmas

People Mix A researcher advising the UK government warned that there are “significant risks” from various households during the holiday season, particularly for older people who are more prone to severe Covid-19. Socializing during the holidays is likely to lead to increased contact between the younger generations “with high rates of infection” and the elderly, said Andrew Hayward of University College London, who is a member of the government’s scientific advisory group on emergencies. “In my personal view, we put way too much emphasis on a near-normal Christmas,” Hayward told BBC Radio 4. “We know that respiratory infections peak in January, so it can only help fuel over Christmas to throw into the fire. ” “England entered a four-week nationwide lockdown on November 8th, slated to end on December 2nd. The UK government is expected to come up with proposals to ease restrictions in December next week.

The city of Hull currently has the highest infection rate in England at 751 per 100,000 people compared to 274 per 100,000 across England. Local MPs have sought help from the UK government, including helping the military run mass tests in the city. Last week the military was deployed to aid the NHS Mass tests in Liverpool. The government said its coronavirus task force will speak to leaders in Hull about response measures.

Other coronavirus news

Preliminary results suggest An arthritis drug can improve results with severe covid-19. The results, which have not yet been published or peer-reviewed, indicate that critically ill Covid-19 patients treated with Roche’s anti-inflammatory drug Actemra are more likely to survive after being hospitalized for Covid-19 . The drug, also known as tocilizumab, is one of several drugs evaluated in the REMAP-CAP study conducted in the UK by researchers from Imperial College London and the National Audit & Research Center for Critical Care Medicine. Other studies have shown mixed results on the effectiveness of tocilizumab in Covid-19 patients, said Athimalaipet Ramanan of the University of Bristol in a Explanation.

The Oxford-AstraZeneca coronavirus vaccine candidate is safe and induces one Immune response in people in their 60s and 70sAccording to the results of a phase II study in the lancet. The results are based on a study on 560 volunteers. The results are significant as the risk of severe Covid-19 increases with age. Data from ongoing Phase III trials will show whether the vaccine candidate can prevent people from developing Covid-19.

The number of Covid-19 patients in US hospitals has increased doubled in the last month, with a new record number of hospital stays reported every day this week. Almost 77,000 people were hospitalized with the covid-19 on Tuesday and in the United States More than 250,000 people have died of the disease in the country since the beginning of its epidemic.

Coronavirus deaths

Standard image of the new scientist

The global death toll from Covid-19 has exceeded 1.35 million. The number of confirmed cases is loud. More than 56.4 million Johns Hopkins Universityalthough the true number of cases will be much higher.

Latest information on the coronavirus from New Scientist

Get a vaccine for the world: Once a coronavirus vaccine is approved, it will be time to tackle the greatest logistical challenge in history to spread it around the world.

More on these topics: